Odyssey Therapeutics ODTX Balance Sheet (2022-2026)

NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

Odyssey Therapeutics Quarterly Balance Sheet

Periods 11 quarters
Latest Sep 2026

Odyssey Therapeutics reported total assets of $438.10M and total liabilities of $62.33M for the quarter ended Sep 2026. This balance sheet covers 11 quarters of results from Dec 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2022 Dec2023 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 241.04M52.55M39.44M59.14M54.91M163.00M49.52M41.69M35.72M82.03M80.64M
Short-term InvestmentsInvestments (Current) 134.45M115.47M70.22M139.67M140.03M228.54M245.36M
Cash & Current Investments 241.04M187.00M154.90M129.35M54.91M163.00M49.52M181.36M175.75M310.58M326.00M
Receivables - NetNet Receivables 0.44M
Receivables 0.44M
Prepaid Assets 7.67M5.54M4.93M6.16M9.30M9.35M10.89M11.80M
Current Assets 248.71M192.54M159.83M135.51M190.66M185.10M321.46M337.80M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 17.88M15.98M12.86M12.10M7.21M6.56M4.88M4.63M
Long-Term Investments 29.10M35.20M122.49M60.99M
Goodwill 12.88M13.55M14.25M13.35M14.33M14.07M14.10M14.12M
Intangibles 1.18M0.91M0.70M0.57M0.26M0.16M0.09M
Goodwill & Intangibles 14.06M14.46M14.95M13.92M14.59M14.23M14.19M14.12M
Long-Term Deferred Tax 0.01M0.01M
Other Non-Current Assets 1.61M3.69M5.48M8.54M3.33M5.26M3.79M4.43M
Non-Current Assets 68.44M93.99M61.70M61.93M79.13M43.97M162.39M100.30M
Assets 317.15M286.52M221.54M197.44M269.79M229.07M483.85M438.10M
Liabilities
Current Liabilities
Accounts Payables 8.05M7.73M5.33M6.32M7.87M8.22M7.67M8.26M
Payables 8.05M7.73M5.33M6.32M7.87M8.22M7.67M8.26M
Accumulated Expenses 11.39M10.50M15.33M17.52M13.39M8.62M15.16M12.31M
Other Accumulated Expenses 0.37M0.40M0.49M0.84M
Current Leases 1.72M3.86M4.45M4.58M5.21M5.37M5.47M5.53M
Current Taxes 196.03M216.50M
Total Current Liabilities 22.80M22.09M25.11M28.42M26.48M22.21M28.30M26.10M
Non-Current Liabilities
Non-Current Debt 4.76M
Minority Interest 703.56M703.56M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax -0.01M-0.01M
Operating Leases 34.38M30.52M27.64M26.43M21.90M20.75M19.36M17.95M
Other Non-Current Liabilities 1.63M469.00358.00
Total Non-Current Liabilities 68.51M579.96M758.07M
Total Liabilities 70.14M549.23M570.80M579.96M758.07M752.76M62.63M62.33M
Shareholder's Equity
Total Debt 4.76M
Common Equity -262.71M-349.27M-382.53M-417.17M-436.36M-460.80M-488.28M-523.69M421.22M375.77M
Liabilities and Shareholders Equity 317.15M286.52M221.54M197.44M269.79M229.07M483.85M438.10M
Retained Earnings -289.09M-382.66M-419.49M-568.14M-606.40M-659.19M-712.25M

Odyssey Therapeutics Balance Sheet API

Pull Odyssey Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ODTX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY